Immatics Biotechnologies Granted United States Patent for Immunotherapy Against Several Tumors of the Blood, Such as Acute Myeloid Leukemia (AML)

Published date24 February 2021
According to the abstract released by the U.S. Patent and Trademark Office: "The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT